참고문헌
- Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest 1983;49:208-15.
- Dussaillant GR, Mintz GS, Pichard AD, et al. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll Cardiol 1995;26:720-4. https://doi.org/10.1016/0735-1097(95)00249-4
- Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 1996;94:1247-54. https://doi.org/10.1161/01.CIR.94.6.1247
- Schwartz SM, deBlois D, O'Brien ER. The intima: soil for atherosclerosis and restenosis. Circ Res 1995;77:445-65. https://doi.org/10.1161/01.RES.77.3.445
- Hemminki A, Markie D, Tomlinson I, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998;391:184-7. https://doi.org/10.1038/34432
- Jenne DE, Reimann H, Nezu J, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998;18:38-43. https://doi.org/10.1038/ng0198-38
- Ylikorkala A, Rossi DJ, Korsisaari N, et al. Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science 2001;293:1323-6. https://doi.org/10.1126/science.1062074
- Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-31. https://doi.org/10.1016/S0092-8674(00)81871-1
- Sherr CJ. Mammalian G1 cyclins and cell cycle progression. Proc Assoc Am Physicians 1995;107:181-6.
- Tiainen M, Vaahtomeri K, Ylikorkala A, Makela TP. Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1). Hum Mol Genet 2002;11:1497-504. https://doi.org/10.1093/hmg/11.13.1497
- Tiainen M, Ylikorkala A, Makela TP. Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. Proc Natl Acad Sci U S A 1999;96:9248-51. https://doi.org/10.1073/pnas.96.16.9248
- Karuman P, Gozani O, Odze RD, et al. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell 2001;7:1307-19. https://doi.org/10.1016/S1097-2765(01)00258-1
- Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 1996;98:2277-83. https://doi.org/10.1172/JCI119038
- Kwon JS, Park NK, Jeong IH, et al. A slight variation in the age of rats commonly used as a carotid artery injury model results in a large difference in neointima formation. Korean Cicr J 2007;37:78-83. https://doi.org/10.4070/kcj.2007.37.2.78
- Kwon JS, Park SS, Kim YG, et al. Perivascular delivery of paclitaxel with F-127 pluronic gel inhibits neointimal hyperplasia in a rat carotid injury model. Korean Circ J 2005;35:221-7.
- Joe JH, Lim KS, Jin JY, Kim KS. Effect of udenafil vascular smooth muscle cell proliferation and neointimal hyperplasia in rat carotid artery injury model. Korean Circ J 2008;38:320-4. https://doi.org/10.4070/kcj.2008.38.6.320
- Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury: I. smooth muscle growth in the absence of endothelium. Lab Invest 1983;49:327-33.
- Sharpless NE, Ramsey MR, Balasubramanian P, Castrillon DH, DePinho RA. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis. Oncogene 2004;23:379-85. https://doi.org/10.1038/sj.onc.1207074
- Kim DW, Chung HK, Park KC, et al. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC). Mol Endocrinol 2007;21:3039-49. https://doi.org/10.1210/me.2007-0269
- Nagata D, Takeda R, Sata M, et al. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation 2004;110:444-51. https://doi.org/10.1161/01.CIR.0000136025.96811.76
- Kojima K, Motoshima H, Tsutsumi A, et al. Rottlerin activates AMPK possibly through LKB1 in vascular cells and tissues. Biochem Biophys Res Commun 2008;376:434-8. https://doi.org/10.1016/j.bbrc.2008.09.007
- Chan AY, Dyck JR. Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy. Can J Physiol Pharmacol 2005;83:24-8. https://doi.org/10.1139/y04-107
- Chan AY, Soltys CL, Young ME, Proud CG, Dyck JR. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. J Biol Chem 2004;279:32771-9. https://doi.org/10.1074/jbc.M403528200
- Motoshima H, Goldstein BJ, Igata M, Araki E. AMPK and cell proliferation: AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol 2006;574:63-71. https://doi.org/10.1113/jphysiol.2006.108324
- Marignani PA, Kanai F, Carpenter CL. LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest. J Biol Chem 2001;276:32415-8. https://doi.org/10.1074/jbc.C100207200
피인용 문헌
- AMP-activated protein kinase and the control of smooth muscle cell hyperproliferation in vascular disease vol.56, pp.1, 2010, https://doi.org/10.1016/j.vph.2011.10.003
- Retinoid X Receptor Agonists Inhibit Hypertension-Induced Myocardial Hypertrophy by Modulating LKB1/AMPK/p70S6K Signaling Pathway vol.27, pp.8, 2010, https://doi.org/10.1093/ajh/hpu017